Guidance for industry : changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture.
Other author/creator | Center for Biologics Evaluation and Research (U.S.) |
Format | Electronic and Book |
Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2001] |
Description | i, 30 p. : digital, PDF file |
Supplemental Content | https://purl.fdlp.gov/GPO/LPS113200 |
Subject(s) |
Click here for more information about this title
Portion of title | Changes to an approved application |
Portion of title | Biological products, human blood and blood components intended for transfusion or for further manufacture |
General note | Title from PDF title page (viewed on May 28, 2009). |
General note | "July 2001". |
General note | GPO Cataloging Record Distribution Program (CRDP). |
Bibliography note | Includes bibliographical references (p. 25-26). |
Technical details | Mode of access: Internet at the FDA CBER web site. Address as of 5/28/09: http://www.fda.gov/cber/gdlns/bldchanges.pdf ; current access is available via PURL. |
GPO item number | 0499-T-02 (online) |
Govt. docs number | HE 20.4802:B 52/4 |
Available Items
Library | Location | Call Number | Status | Item Actions | |
Joyner | Electronic Resources | Access Content Online | ✔ Available |